-
1541por Yair-Sabag, Shira, Nussinson, Elchanan, Ben-Assuli, Ofir, Shibli, Fahmi, Shahbari, Azmi, Zelber-Sagi, Shira“…AIM: To evaluate the bidirectional association between metabolic syndrome (MS) components and antiviral treatment response for chronic hepatitis C virus (HCV) infection. METHODS: This retrospective cohort study included 119 HCV + patients treated with pegylated-interferon-α and ribavirin. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1542por Fouad, Hanan, El Raziky, Maissa, Hassan, Eman Medhat, Aziz, Ghada Mahmoud Abdel, Darweesh, Samar K, Sayed, Ahmed Reda“…AIM: To investigate how Tregs are regulated in chronic hepatitis C virus (HCV) patients via assessment of Tregs markers (granzyme 2, CD69 and FoxP3), Teffs markers [TNFRSF4 (OX40), INFG] and CD4, CD25 genes. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1543“…Hepatitis C virus (HCV) has infected 3% of the population worldwide and 20% of the population in Egypt. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1544por Kim, Do Young, Han, Kwang-Hyub, Jun, Byungyool, Kim, Tae Hyun, Park, Sohee, Ward, Thomas, Webster, Samantha, McEwan, Phil“…BACKGROUND AND AIMS: This study aims to investigate the cost-effectiveness of a one-time hepatitis C virus (HCV) screening and treatment program in South Korea where hepatitis B virus (HBV) prevails, in people aged 40–70, compared to current practice (no screening). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1545por Suda, Toshikuni, Okawa, Osamu, Masaoka, Rion, Gyotoku, Yoshinori, Tokutomi, Naohiko, Katayama, Yasumi, Tamano, Masaya“…AIM: To investigate shear wave (SW) propagation velocity in patients with untreated hepatitis C and patients with sustained virological response (SVR). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1546por Ding, Yan-Hua, Liu, Bin, Zhang, Xin, Sun, Li, Zhang, Hong, Luo, Hua, Sun, Yan-Fu, Liu, Cheng-Jiao, Zhang, Qi, Cao, Yu-Chen, Chen, Hong, Niu, Jun-Qi“…PEG-CIFN is well tolerated, and was found to have dose-dependent effectiveness in subjects with chronic hepatitis C. Virological response rates between PEG-CIFN 1.5 or 2.0 µg/kg, and pegylated IFNα-2a were similar, and not significantly different. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1547por Sofian, Masoomeh, Ramezani, Amitis, Imani, Hossein, Farazi, Ali Asghar, Banifazl, Mohammad, Jourabchi, Ali, Aghakhani, Arezoo“…BACKGROUND AND OBJECTIVES: Hepatitis C virus (HCV) infection is a worldwide concern and it is the major cause of liver disease. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1548
-
1549por Welsch, Christoph, Efinger, Mira, von Wagner, Michael, Herrmann, Eva, Zeuzem, Stefan, Welzel, Tania M., Lange, Christian M.Enlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1550por Berera, Shivali, Gomez, Alexandra, Dholaria, Kevin, Arosemena, Leopoldo R., Ladino-Avellaneda, Marco A., Barisoni, Laura, Bhamidimarri, Kalyan R.Enlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1551por Mutagoma, Mwumvaneza, Balisanga, Helene, Sebuhoro, Dieudonné, Mbituyumuremyi, Aimable, Remera, Eric, Malamba, Samuel S., Riedel, David J., Nsanzimana, Sabin“…BACKGROUND: Hepatitis C virus (HCV) infection is a pandemic causing disease; more than 185 million people are infected worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1552por Ponziani, Francesca Romana, Mangiola, Francesca, Binda, Cecilia, Zocco, Maria Assunta, Siciliano, Massimo, Grieco, Antonio, Rapaccini, Gian Lodovico, Pompili, Maurizio, Gasbarrini, Antonio“…Hepatitis C virus (HCV) infection has been a global health problem for decades, due to the high number of infected people and to the lack of effective and well-tolerated therapies. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1553por Hernández-Alvarez, Noemi, Pascasio Acevedo, Juan Manuel, Quintero, Enrique, Fernández Vázquez, Inmaculada, García-Eliz, María, de la Revilla Negro, Juan, Crespo García, Javier, Hernández-Guerra, Manuel“…BACKGROUND AND AIMS: Rapid viral response (RVR) during antiviral treatment for hepatitis C virus (HCV) predicts sustained viral response (SVR). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1554“…BACKGROUND: Healthcare workers infected with Hepatitis B (HBV) or Hepatitis C virus (HCV) may undertake patient care activities if provider-to-patient transmission risks have been assessed in terms of viral load and clinical procedures. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1555“…African Americans (AA) in the US are twice as likely to be infected with hepatitis C virus (HCV) compared to the non-Hispanic-white US population (Cau). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1556Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvirpor Younossi, Zobair M., Stepanova, Maria, Omata, Masao, Mizokami, Masashi, Walters, Mercedes, Hunt, Sharon“…The interferon (IFN)-free regimens for chronic hepatitis C (CHC) have high efficacy and superior health-related quality of life (HRQOL) in European/North American patients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1557“…BACKGROUND: The seroprevalence of hepatitis C varies substantially between countries and geographic regions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1558por Rehman, Ghani Ur, Ali, Mohammad, Shah, Farooq, Iqbal, Amjad, Ahmad, Ayaz, Hayat, Zafar, Islam, Badshah, Ali, Farman, Ikramullah, Jamal, Yousaf, Alam, Sartaj, Sajjad, Muhammad, Bhatti, Muhammad Zeeshan“…Hepatitis C (HCV) and diabetes mellitus are the two main health concerns that cause devastating health and financial worries worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1559por AHMADI GHEZELDASHT, Sanaz, HEDAYATI-MOGHADDAM, Mohammad Reza, SHAMSIAN, Khosro, FATHIMOGHADAM, Farhad, BIDKHORI, Hamid Reza, REZAEE, Seyed Abdolrahim“…BACKGROUND: Hepatitis C Virus (HCV) infection is one of the major blood-borne infections worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1560por Yamazaki, Tomoo, Joshita, Satoru, Umemura, Takeji, Usami, Yoko, Sugiura, Ayumi, Fujimori, Naoyuki, Shibata, Soichiro, Ichikawa, Yuki, Komatsu, Michiharu, Matsumoto, Akihiro, Igarashi, Koji, Tanaka, Eiji“…We sought to clarify the diagnostic ability of ATX for liver fibrosis in 593 biopsy-confirmed hepatitis C virus (HCV)-infected patients. The diagnostic accuracy of ATX was compared with clinical parameters and the established fibrosis biomarkers Wisteria floribunda agglutinin-positive Mac-2-binding protein, FIB-4 index, AST-to-platelet ratio, and Forn’s index. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto